Granules India secures first-to-file status for their drug Lumryz, which belongs to the complex generic drug category and is a cure for narcolepsy, a neurological disorder that affects the brain's ability to regulate sleep
The new study from TATA Memorial has found ou that papaya leaf extracts are capable of reducing chemo side effects like reduced platelet counts and bleeding associated with it
Glenmark has expanded its presence in the US pharmaceutical market with the launch of its Fast-Acting Schizophrenia Injection, a generic version of Olanzapine for Injection, 10 mg/vial.
The Indian government has taken a major step to improve digital healthcare with the launch of the digital service, called the Bharat Health Terminology Service (BHTS).
Researchers have developed a new one injection treatment that could reduce the need for osteoarthritis surgery in the future.
New Cancer Blood Test is set to change the way early cancer detection is approached in India. Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield Multi-Cancer Detection Test, a blood-based screening test that can...
The Pharma Industry witnessed another eventful week, with developments across regulation, innovation, manufacturing, and public health.
NITI Aayog steps up to taking the indian traditional healthcare into global attention, with further evidence-based research and development, Ayurveda is expected to be popularised globally for its efficiency in preventive healthcare solutions.
Kerala Patients have received a major reassurance after the state government ruled out the hospital privatization of any government hospitals.
The Hyderabad Pharma Firm, Shantha Biologics, has secured a major manufacturing agreement with Novo Nordisk, marking another milestone for India's pharmaceutical sector.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")